Cash support to help people with HIV in Tanzania stay in care
Strengthening the continuity of HIV care in Tanzania with economic support
This project offers financial incentives to people with HIV in Tanzania to help them re-engage with care and stick to antiretroviral treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11123262 on NIH RePORTER |
What this research studies
If you live with HIV in Tanzania and have missed clinic visits or struggle to take your medicines, this project offers money to help you return to care and keep taking ART. The team is building on a pilot that found a one-time payment was acceptable and helped people come back to care. Over five years they will use behavioral-economics methods and mixed qualitative and quantitative approaches to see whether incentives improve clinic attendance, medication adherence, and viral suppression. The project will also include interviews and follow-up to learn which forms of support work best for participants.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV in Tanzania who have fallen out of care or who are struggling to adhere to ART.
Not a fit: People who are already consistently in HIV care and virally suppressed, or those living outside Tanzania, are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this approach could help more people stay in care, increase viral suppression, and reduce onward HIV transmission.
How similar studies have performed: Earlier work, including the team's Tanzanian pilot, showed one-time financial incentives were feasible and promising, but evidence on long-term retention and use for people already disengaged is still limited.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Wang, Jingshen — University of California Berkeley
- Study coordinator: Wang, Jingshen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.